Sustaining Biotech Innovation in an Era of Austerity     Print Email
Wednesday, 29 June 2011

On June 29, 2011, Stéphane Hogan, Head of Coordination Unit in Directorate Health of DG Research and Innovation and Giulia Del Brenna, Head of Unit for Food and Healthcare Industries, Biotechnology in DG Enterprise and Industry both of the European Commission, David Beier, Senior Vice President for Global Government and Corporate Affairs at Amgen, and Dr. Val Giddings, Senior Fellow at the Information Technology and Innovation Foundation addressed U.S. and EU approaches to spurring innovation in the biotechnology sector in a time of budgetary constraints and growing concerns over rising healthcare costs. The Honorable Bart Gordon, Partner at K&L Gates LLP and former Chairman of the U.S. House Committee on Science and Technology, moderated the discussion.